Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Ophthotech Corp (OPHT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C3461)・商品コード:DATA904C3461
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is supposed to be used in the development of AMD. It also provides Fovista, an anti-platelet-derived growth factor (PDGF). Ophthotech offers gene therapy research programs, dry age-related macular degeneration and ophthalmic orphan programs. The company utilizes aptamer technology, a single strand of nucleic acid to targets such as PDGF, comparable to a monoclonal antibody. Its Fovista is used to inhibit abnormal new blood vessel growth associated with wet AMD. The company has its operations in New York and Princeton, the US. Ophthotech is headquartered in New York, the US.

Ophthotech Corp (OPHT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ophthotech Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ophthotech Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ophthotech Raises US$83.3 Million In Series C Financing 11
Ophthotech Raises Funds Through Venture Financing 13
Ophthotech Raises Funds Through Venture Financing 14
Ophthotech Raises Funds Through Venture Financing 15
Partnerships 16
Ophthotech and University of Pennsylvania Enter into Agreement 16
Ophthotech Enters into Research Agreement with University of Massachusetts Medical School 17
Ophthotech Enters into Agreement with Foundation Fighting Blindness 18
Midatech Pharma Enters into Agreement with Ophthotech 19
International Drug Development Institute Partners with Ophthotech 20
Licensing Agreements 21
Ophthotech Enters into Licensing Agreement with University of Florida Research Foundation and the University of Pennsylvania 21
Ophthotech Amends Licensing Agreement with Novartis 22
Equity Offering 24
Ophthotech Plans to Raise up to USD150 in Public Offering of Securities 24
Ophthotech Completes Public Offering Of Shares For US$60 Million 25
Ophthotech Completes IPO For US$192.3 Million 26
Ophthotech Corp – Key Competitors 27
Ophthotech Corp – Key Employees 28
Ophthotech Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Feb 01, 2017: Ophthotech Announces Strategic Review Plan 30
Financial Announcements 31
Aug 01, 2018: Ophthotech Reports Second Quarter 2018 Financial and Operating Results 31
May 09, 2018: Ophthotech announces Q1 2018 results 33
Feb 27, 2018: Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results 35
Nov 08, 2017: Ophthotech Reports Third Quarter 2017 Financial and Operating Results 37
Jul 26, 2017: Ophthotech Reports Second Quarter 2017 Financial and Operating Results 39
Jul 26, 2017: Ophthotech Q2 net loss decreases 40
May 03, 2017: Ophthotech Reports First Quarter 2017 Financial and Operating Results 41
Feb 28, 2017: Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results 42
Corporate Communications 43
Jan 16, 2018: Ophthotech Announces Election of Jane Pritchett Henderson to Its Board of Directors 43
Apr 24, 2017: Ophthotech Announces Leadership Transition Effective July 1, 2017 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Ophthotech Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ophthotech Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ophthotech Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ophthotech Raises US$83.3 Million In Series C Financing 11
Ophthotech Raises Funds Through Venture Financing 13
Ophthotech Raises Funds Through Venture Financing 14
Ophthotech Raises Funds Through Venture Financing 15
Ophthotech and University of Pennsylvania Enter into Agreement 16
Ophthotech Enters into Research Agreement with University of Massachusetts Medical School 17
Ophthotech Enters into Agreement with Foundation Fighting Blindness 18
Midatech Pharma Enters into Agreement with Ophthotech 19
International Drug Development Institute Partners with Ophthotech 20
Ophthotech Enters into Licensing Agreement with University of Florida Research Foundation and the University of Pennsylvania 21
Ophthotech Amends Licensing Agreement with Novartis 22
Ophthotech Plans to Raise up to USD150 in Public Offering of Securities 24
Ophthotech Completes Public Offering Of Shares For US$60 Million 25
Ophthotech Completes IPO For US$192.3 Million 26
Ophthotech Corp, Key Competitors 27
Ophthotech Corp, Key Employees 28
Ophthotech Corp, Other Locations 29

List of Figures
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ophthotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★調査レポート[Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C3461)販売に関する免責事項を必ずご確認ください。
★調査レポート[Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆